Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO
Avalyn Pharma Inc., a biopharma company developing inhaled treatments for respiratory diseases, filed for a US initial public offering.
Buildings outside of South Station in Boston.
Buildings outside of South Station in Boston.